Tag Archives: progression-free survival
Axicabtagene Ciloleucel Improves Survival in Large B-Cell Lymphoma
Axicabtagene ciloleucel (Yescarta) significantly improves survival in large B-cell lymphoma compared to standard treatment. This.....Read more
05
Dec
Dec
Advances in Multiple Myeloma Treatment: Immunotherapies and Targeted Therapies
Almost a decade ago, the FDA approved daratumumab (Darzalex), a groundbreaking monoclonal antibody for multiple.....Read more
26
Nov
Nov
Daratumumab-Based Quadruplet Therapy Improves Outcomes in Multiple Myeloma: CEPHEUS Trial Results
Multiple myeloma treatment has seen significant advancements in recent years. The CEPHEUS trial, presented at.....Read more
26
Nov
Nov
Ribociclib Plus Endocrine Therapy Shows Consistent Benefit and Safety in Elderly Patients with Advanced Breast Cancer
Ribociclib plus endocrine therapy offers consistent benefits for elderly patients with HR+, HER2- advanced breast.....Read more
26
Nov
Nov